These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28407786)

  • 1. Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
    Li L; Cai S; Liu S; Feng H; Zhang J
    J Ovarian Res; 2017 Apr; 10(1):27. PubMed ID: 28407786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
    Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
    Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive bioinformatics analysis confirms RBMS3 as the central candidate biological target for ovarian cancer.
    Wang M; Fu X; Wang W; Zhang Y; Jiang Z; Gu Y; Chu M; Shao Y; Li S
    Med Eng Phys; 2022 Dec; 110():103883. PubMed ID: 36075788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
    Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
    Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network-pathway based module identification for predicting the prognosis of ovarian cancer patients.
    Wang X; Wang SS; Zhou L; Yu L; Zhang LM
    J Ovarian Res; 2016 Nov; 9(1):73. PubMed ID: 27806724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
    Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
    J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
    Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
    Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer.
    Yan B; Xiong C; Huang F; Zhang M; Mo Y; Bai H
    Medicine (Baltimore); 2020 Jul; 99(27):e20802. PubMed ID: 32629664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of the Stemness Index in Ovarian Cancer Prognosis.
    Yuan H; Yu Q; Pang J; Chen Y; Sheng M; Tang W
    Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
    Gyorffy B; Lánczky A; Szállási Z
    Endocr Relat Cancer; 2012 Apr; 19(2):197-208. PubMed ID: 22277193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of TET3 predicts unfavorable prognosis in patients with ovarian cancer-a bioinformatics integrative analysis.
    Cao T; Pan W; Sun X; Shen H
    J Ovarian Res; 2019 Oct; 12(1):101. PubMed ID: 31656201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenylate kinase 7 is a prognostic indicator of overall survival in ovarian cancer.
    Zhang XY; Zhou LL; Jiao Y; Li YQ; Guan YN; Zhao YC; Zheng LW
    Medicine (Baltimore); 2021 Jan; 100(1):e24134. PubMed ID: 33429787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
    Duan C; Li K; Pan X; Wei Z; Xiao L
    BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A thirteen‑gene set efficiently predicts the prognosis of glioblastoma.
    Yang H; Jin L; Sun X
    Mol Med Rep; 2019 Mar; 19(3):1613-1621. PubMed ID: 30628650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
    Wang S; Wang C; Liu O; Hu Y; Li X; Lin B
    Life Sci; 2021 Jul; 277():119461. PubMed ID: 33811900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic 11 genes expression model for ovarian cancer.
    Men CD; Liu QN; Ren Q
    J Cell Biochem; 2018 Feb; 119(2):1971-1978. PubMed ID: 28817186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer classification and prognosis assessment model based on prognostic target genes in key microRNA-target gene networks.
    Chen X; Li Y; He J
    J Gene Med; 2024 Jan; 26(1):e3575. PubMed ID: 37548130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.